Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 17 » default
Clinical Pharmacology: Advances and Applications
- View all (303)
- Volume 18, 2026 (10)
- Volume 17, 2025 (23)
- Volume 16, 2024 (3)
- Volume 15, 2023 (12)
- Volume 14, 2022 (12)
- Volume 13, 2021 (27)
- Volume 12, 2020 (28)
- Volume 11, 2019 (16)
- Volume 10, 2018 (19)
- Volume 9, 2017 (19)
- Volume 8, 2016 (20)
- Volume 7, 2015 (14)
- Volume 6, 2014 (23)
- Volume 5, 2013 (30)
- Volume 4, 2012 (11)
- Volume 3, 2011 (7)
- Volume 2, 2010 (28)
- Volume 1, 2009 (1)
Archive: Volume 17, 2025
The Emerging Role of Liposomal Bupivacaine in Erector Spinae Plane Blocks for Post-Operative Pain Management in Spine Surgeries: A Narrative Review
Delaney JB, Landry LP, Coggins NC, Ahmadzadeh S, Patil SS, Dorius B, Shekoohi S, Kaye AD
Clinical Pharmacology: Advances and Applications 2025, 17:339-346
Published Date: 22 December 2025
Research Progress on the Clinical Application of Remimazolam Outside the Operating Room: A Review of Pharmacological Characteristics, Clinical Effects, and Safety
Luo H, Zhou C, Qu Y, Kuang X
Clinical Pharmacology: Advances and Applications 2025, 17:329-337
Published Date: 18 December 2025
Pharmacotherapy for Obesity: Recent Updates
Fredrick TW, Camilleri M, Acosta A
Clinical Pharmacology: Advances and Applications 2025, 17:305-327
Published Date: 19 September 2025
Bioactive Compounds From Saudi Arabian Fungi: A Systematic Review of Anticancer Potential
Alghamdi SS, Alamre JH, Alsubait A, Alanzi AR, Aldawish BS, Althobiti F, Al Rudhyyan MI, Almadi AM, Mohammed AE
Clinical Pharmacology: Advances and Applications 2025, 17:291-304
Published Date: 4 September 2025
Monascus purpureus Red Yeast Rice: A Review of the in vitro and in vivo Pharmacological Activities, Studies in Humans, and Case Reports
Shaleha RR, Yuliana A, Amin S, Levita J, Sumiwi SA
Clinical Pharmacology: Advances and Applications 2025, 17:269-289
Published Date: 3 September 2025
Metabolomics Insights into the Benefits of SGLT2 Inhibitors in Type 2 Diabetes
Kyriakidou A, Koufakis T, Gika H, Kotsa K
Clinical Pharmacology: Advances and Applications 2025, 17:253-267
Published Date: 31 August 2025
Determination of 5-Fluorouracil in Dried Blood Spots for Therapeutic Drug Monitoring and Adverse Event Assessment in Breast Cancer Patients
Hanifah M, Harahap Y, Purwanto DJ
Clinical Pharmacology: Advances and Applications 2025, 17:243-251
Published Date: 29 August 2025
Recurrent Checkpoint Inhibitor-Related Pneumonitis Refractory to Corticosteroid Treatment: A Case Report and Literature Review
Yu J, Liu X, Ma X, Liang L, Liu Y, Yin W, Li Q, Cao B, Liu W
Clinical Pharmacology: Advances and Applications 2025, 17:235-242
Published Date: 19 August 2025
Optimizing Antimicrobial Use in Japan: Strategies for Dosage, Combination Therapy, De-Escalation, Oral Switching, Duration, and Guideline Adherence
Seki M
Clinical Pharmacology: Advances and Applications 2025, 17:227-233
Published Date: 4 August 2025
Dose Optimization of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia
Chen J, Zhu Y, Zhao Y, Guo N, Yao Y, Luo X, Huang L
Clinical Pharmacology: Advances and Applications 2025, 17:211-225
Published Date: 30 July 2025
Immunotherapy in Glioblastoma: An Overview of Current Status
Sarfraz Z, Maharaj A, Venur VA, Lathia JD, Odia Y, Ahluwalia MS
Clinical Pharmacology: Advances and Applications 2025, 17:185-209
Published Date: 24 July 2025
Immunotherapy in Gastrointestinal Cancers: Current Insights
Jiang X, Zhan Y, Yang DH, Bao L
Clinical Pharmacology: Advances and Applications 2025, 17:167-183
Published Date: 23 July 2025
Diagnostic Significance of Paraneoplastic Neuronal Antibodies in Japanese Adults with Autoimmune Encephalitis: A Case Series Study in an Adult Epilepsy Clinic
Kinoshita M, Takada K, Ohara H, Sai T, Elangovan A, Suresh Babu HW, Vellingiri B, Satow T
Clinical Pharmacology: Advances and Applications 2025, 17:155-166
Published Date: 30 June 2025
The Effect of Drug–Drug Interactions on the Pharmacokinetics of Isavuconazole: A Comprehensive Review
Sang Y, Xu Q, Gao A, Zhao Q
Clinical Pharmacology: Advances and Applications 2025, 17:143-153
Published Date: 17 June 2025
Triphenylphosphine-Based Mitochondrial Targeting Nanocarriers: Advancing Cancer Therapy
Ali MS, Gowda BHJ, Shukla R, Kesharwani P
Clinical Pharmacology: Advances and Applications 2025, 17:119-141
Published Date: 10 June 2025
Novel Therapies in Primary Central Nervous System Lymphoma
Wakim M, Mezher M, Perez-Perez A, Maharaj A, Odia Y, Ahluwalia MS, Linhares Y
Clinical Pharmacology: Advances and Applications 2025, 17:97-117
Published Date: 28 May 2025
Predictive Analysis of Non-Cardiac Drug-Induced QTc Interval Prolongation: A Cross-Sectional Study
Albekairy NA, Aldawsari RA, Alanazi S, Almutairi N, AlSayari N, Abu Al-Burak S, Bawazeer MA, Alfehaid L, Shawaqfeh MS
Clinical Pharmacology: Advances and Applications 2025, 17:85-96
Published Date: 13 May 2025
A Case Report of Sustained Cytokine Release Syndrome Due to Glofitamab and Literature Review
Yang J, Shen Q, Ke X, Liu W, Yang P
Clinical Pharmacology: Advances and Applications 2025, 17:79-83
Published Date: 29 April 2025
Parametric Population Pharmacokinetics Model Repository of Rifampicin: Model-Informed Individualized Therapy
Ju G, Liu X, Gu M, Chen L, Wang X, Li C, Yang N, Zhang G, Zhang C, Zhu X, He Q, Ouyang D
Clinical Pharmacology: Advances and Applications 2025, 17:49-78
Published Date: 15 April 2025
Current Developments in Malaria Vaccination: A Concise Review on Implementation, Challenges, and Future Directions
Sallam M, Al-Khatib AO, Al-Mahzoum KS, Abdelaziz DH, Sallam M
Clinical Pharmacology: Advances and Applications 2025, 17:29-47
Published Date: 1 April 2025
Hypersensitivity Reaction After Administration of Crotalidae Polyvalent Immune Fab (CroFab)
Truong L, Anis TR, Najibfard L, Peck E
Clinical Pharmacology: Advances and Applications 2025, 17:25-28
Published Date: 11 March 2025
The Therapeutic Effects of Curcumin on Oral Disease: A Systematic Review
Indriyani N, Nur’aeny N
Clinical Pharmacology: Advances and Applications 2025, 17:13-24
Published Date: 27 February 2025
Efficacy and Safety of Antimalarial as Repurposing Drug for COVID-19 Following Retraction of Chloroquine and Hydroxychloroquine
Latarissa IR, Khairinisa MA, Iftinan GN, Meiliana A, Sormin IP, Barliana MI, Lestari K
Clinical Pharmacology: Advances and Applications 2025, 17:1-11
Published Date: 16 January 2025